The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 26th 2024
Once relatively obscure, PBMs are now front and center in debates over drug pricing and access. Their future role will have profound implications not only for how medications are priced but also for how pharmacies conduct their operations.
Following Pause of Johnson & Johnson COVID-19 Vaccine, Experts Continue Monitoring for Safety
April 30th 2021Although the CDC and FDA have lifted the pause on Johnson & Johnson’s COVID-19 vaccine, Humphreys said the vaccine now comes with a warning label, and ongoing safety reviews will be paramount to ensure its continued safety.
Watch
Immune Response From the Gut May Not Provide Systemic Immunity to COVID-19
April 30th 2021If gut-imprinted immune cells are diluted in comparison to immune cells triggered by other parts of the body, there could be implications for the oral-based COVID-19 vaccines currently under development.
Read More
Expert: Pharmacists Are ‘The Heroes of 2021,’ Leading the Charge on Helping to Heal Our Nation
April 29th 2021The efforts of pharmacists to keep their doors open during the pandemic, build COVID-19 testing sites, and prepare for and administer COVID-19 vaccinations took extraordinary investment and determination.
Read More
IQVIA Report Finds Disrupted Medication Use During COVID-19 Pandemic, Including Long-Term Challenges
April 29th 2021In addition to altered supply chains and medication access during the early months of the pandemic, the report predicts long-term changes for both COVID-19 survivors and those with chronic illnesses.
Read More
US Senate Joins House in Sponsoring Legislation Expanding Medicare Access to Pharmacy Services
April 28th 2021Bipartisan legislation has been introduced in the US Senate that would give millions of Medicare patients in medically underserved communities access to critical primary health care services delivered by pharmacists across the country.
Read More
Expert: The Fight for Provider Status for Pharmacists ‘Has Just Begun’
April 28th 2021Pharmacy Times® interviewed Scott J. Knoer, MS, PharmD, FASHP, the EVP and CEO of APhA, on how the recently introduced Pharmacy and Medically Underserved Area Enhancement Act may impact pharmacy and health care outlooks.
Watch
Johnson & Johnson Commits to Helping Eradicate Racial, Social Injustice in Health Care
April 27th 2021According to Michael Sneed, executive vice president of global corporate affairs and chief communication officer for Johnson & Johnson, the health care system has chronically left people of color behind, and the inequities seen throughout the COVID-19 pandemic are only the latest examples.
Read More
Patient and Provider Safety is at the Core of Mass COVID-19 Immunization Effort
April 27th 2021As new variants of the virus come to rise, it is crucial to continue to address the safety concerns with mass COVID-19 immunizations during the pandemic as well as provide solutions to reduce the exposure and spread of the virus.
Read More
More Than 100 Patient Groups Advocate for Affordable Prescription Drugs
April 27th 2021Patient and provider organizations urge the Department of Health and Human Services and the Biden administration to enact policies and protections that improve prescription drug affordability for people in the United States.
Read More